Table 1.

Responsive and recurrent tumors, patient clinical information.

Tumor ID	Patient Gender	Age at Dx	Smoking Status	Smoking History	Alcohol Use	HPV Copy Number	Year of Dx	Status	Stage	TNM Classification	Tx
1733	Female	42	Former Smoker	5py × 20y	?	22.5	2009	Alive with NED 52 months from diagnosis	III	T2 N1 M0	Chemo-RTC
1769	Female	60	Non-Smoker	NA	None	475.6	2009	Alive with NED 49 months from diagnosis	III	T3 N1 M0	Surgery
1804	Male	58	Non-Smoker	NA	Social	161.1	2009	Alive with NED 48 months from diagnosis	IVA	T2 N2 M0	Chemo-RTD
1971	Male	51	Non-Smoker	NA	None	538.9	2010	Alive with NED 40 months from diagnosis	III	T1 N1 M0	Chemo-RTD
2148	Male	67	Current Smoker	Daily Cigar	Social	16.1	2010	Alive with NED 34 months from diagnosis	IVB	T1 N3 M0	Chemo-RTD
0732	Male	78	Former SmokerA	80py	2–3 glasses wine/wk	110.7	2005	AWD 105 months from diagnosis	IVA	T4 N2b M0	Chemo-RTD
0843	Male	50	Current Smoker	20 py quit 27y ago	Social	34.1	2005	DWD 75 months from diagnosis	IVA	T4 N1 M0	Chemo-RTD
1040	Male	72	Former SmokerB	light quit 35 yr ago	none for 25y	297.9	2006	DWD 11 months from diagnosis	IVB	T4 N3 M0	Chemo-RTD
2049	Male	56	Non-Smoker	NA	Social	6.3	2010	DWD 18 months from diagnosis	IVA	T4 N2 M0	Chemo-RTD
2238	Male	51	Current Smoker	25py	?	14	2011	DWD 14 months from diagnosis	IVA	T3 N1 M0	Surgery + ChemoE

NED= no evidence of disease, AWD= alive with disease, DWD= died with disease,

^Anon-smoker for 27 years,

^Bnon-smoker for 35 years,

^Cchemotherapy and radiation received at an outside institution, no additional information,

^Dchemotherapy/radiation consisting of carboplatin/paclitaxel and intensity-mediated radiation therapy (IMRT),

^Echemotherapy with weekly cisplatin.